β-glucan combined with Envafolimab and Endostar as immune rechallenge for metastatic non-small cell lung cancer.

Autor: Geng, Qian1,2 (AUTHOR), Lu, Yingying2 (AUTHOR), Li, Dongqing1,2 (AUTHOR), Qin, Lanqun1,2 (AUTHOR), Qi, Chunjian1,3 (AUTHOR), Pu, Xiaolin1,2 (AUTHOR), Zhuang, Yi4 (AUTHOR), Zhu, Yajun5 (AUTHOR), Zha, Quanbin5 (AUTHOR), Wang, Ge1,2 (AUTHOR), Jiang, Hua1,2 (AUTHOR) czeyjh@njmu.edu.cn
Zdroj: BMC Immunology. 9/14/2024, Vol. 25 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje